ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: CDC Seeks Initiatives For Tobacco Control; NCI RFA Available

May 8, 1998

In Brief: Congress Recesses With No More Action On Waxman Bill; BCTF to Look at New Diagnosis, Detection

August 12, 1983

USC $2.5 Million contract Tops Last Minute FY 75 Rush of Awards

July 18, 1975

Leptin Could Be Indicator Of Breast Cancer Risk

April 25, 2003

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

July 25, 2008

Protocols Approved During the Month of June 2002

July 26, 2002